Obesity and Alzheimer's drugs pack one-two punch to power Eli Lilly higher in 2024

Obesity and Alzheimer's drugs pack one-two punch to power Eli Lilly higher in 2024


Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. 

George Frey | Bloomberg | Getty Images

Investor optimism for Eli Lilly‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story.



Source

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Health

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Analysts say […]

Read More
Dental supply stock rallies on theory RFK’s anti-fluoride stance will prompt more dentist visits
Health

Dental supply stock rallies on theory RFK’s anti-fluoride stance will prompt more dentist visits

Robert F. Kennedy Jr. attends a campaign event for Republican presidential nominee and former U.S. President Donald Trump in Milwaukee, Wisconsin, U.S. November 1, 2024.  Joel Angel Juarez | Reuters Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect Donald Trump’s pick for Health and Human […]

Read More
2 health stocks are buys. They’ve been beaten up enough on Trump’s RFK Jr. pick for HHS
Health

2 health stocks are buys. They’ve been beaten up enough on Trump’s RFK Jr. pick for HHS

We are buying 25 shares of Danaher at roughly $229 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 550 shares of DHR, increasing its weighting to roughly 3.6% from 3.4%. The health care sector has been the big loser in the market since the election. If the SPDR Health Care Sector Fund , […]

Read More